Aditi K. Saha

Hematology

619 19th St S
Birmingham, AL 35249

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

From immunomodulators (IMiDs) to cereblon E3 ligase modulator (CELMoDs): the evolution of cereblon modulators in lymphoma therapy.

From immunomodulators (IMiDs) to cereblon E3 ligase modulator (CELMoDs): the evolution of cereblon modulators in lymphoma therapy.

Journal: Leukemia & lymphoma

Published: May 19, 2026

A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma.

A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma.

Journal: Bone marrow transplantation

Published: December 18, 2025

Bispecific antibody combination regimens for B-cell non-Hodgkin's lymphomas.

Bispecific antibody combination regimens for B-cell non-Hodgkin's lymphomas.

Journal: Expert opinion on biological therapy

Published: December 12, 2025

Mutational Profiling Links Biologically Relevant Variants to Multi-Systemic Rosai-Dorfman Disease.

Mutational Profiling Links Biologically Relevant Variants to Multi-Systemic Rosai-Dorfman Disease.

Journal: Blood advances

Published: December 01, 2025

Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challenge.

Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challenge.

Journal: British journal of haematology

Published: September 09, 2025

Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma.

Treatment-related Outcomes and Patterns of Relapse in Secondary CNS Involvement by Large B-cell Lymphoma.

Journal: Blood

Published: September 02, 2025

Indeterminate Dendritic Cell Histiocytosis Harboring ETV3::NCOA2 Translocation with Complete Metabolic Response to MEK Inhibition.

Indeterminate Dendritic Cell Histiocytosis Harboring ETV3::NCOA2 Translocation with Complete Metabolic Response to MEK Inhibition.

Journal: The British journal of dermatology

Published: August 09, 2025

Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.

Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern Era.

Journal: American journal of hematology

Published: May 07, 2025

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

Journal: Blood cancer journal

Published: January 10, 2025

Relocating NSAIDs into the endoplasmic reticulum induces ER stress-mediated apoptosis in cancer cells.

Relocating NSAIDs into the endoplasmic reticulum induces ER stress-mediated apoptosis in cancer cells.

Journal: RSC medicinal chemistry

Published: November 28, 2024

Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma.

Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 12, 2024

Recent developments in CD19-targeted therapies for follicular lymphoma.

Recent developments in CD19-targeted therapies for follicular lymphoma.

Journal: Expert opinion on biological therapy

Published: September 18, 2024

Showing 1-12 of 38

Last Updated: 09/26/2026